Cognitive behavioural therapy for substance use helps a person understand the situations, thoughts, emotions and actions connected with alcohol or drug use. Relapse-prevention work turns that understanding into a practical plan for difficult moments and for responding when use returns. The aim is to develop options and support, not to test willpower.
A useful programme considers both immediate risks and life beyond substance use. Sleep, pain, relationships, housing and mental health can affect what is possible. Learning a coping technique may help, but it should not replace medication, medical care or practical assistance when those are needed.
What is relapse-prevention therapy?
Relapse prevention is a structured way of identifying situations in which a return to harmful use becomes more likely and preparing a response. It often forms part of a cognitive-behavioural treatment programme. The clinician helps connect a particular difficulty with skills that can be practised and reviewed rather than providing a generic list of things to avoid.
NIAAA’s Project MATCH treatment resources describe a defined cognitive-behavioural coping-skills approach for alcohol problems. A service using the term CBT should explain which protocol it offers and how it has been adapted. General CBT for anxiety and a substance-focused programme share some principles but are not automatically interchangeable. NIAAA: cognitive-behavioural coping-skills treatment.
Understanding the chain around substance use
An assessment may examine a recent episode in detail. What happened before it? What were you hoping the substance would change? What followed immediately, and what happened later? This functional analysis is intended to reveal opportunities for a different response, not to produce evidence that you should have known better.
Triggers are not limited to people or places. They can include exhaustion, pain, shame after a disagreement, a celebration or the expectation that an urge cannot be tolerated. At the same time, not every trigger is avoidable. A useful plan distinguishes situations you can change from those that require a workable coping response.
What skills might treatment include?
The work may address responding to urges, declining offers, managing difficult emotions and solving practical problems. A therapist can help you rehearse a conversation or consider what to do when a familiar coping strategy is unavailable. Practice should reflect your circumstances rather than a scenario that exists only in a worksheet.
Beliefs about a setback can also matter. Concluding that one difficult episode means all progress is lost may make seeking help harder. Treatment can challenge that conclusion without minimising the episode’s medical risks. A return to use is a reason to review care promptly, not evidence that the person is beyond help.
Planning rewarding activities and support outside treatment is another useful discussion. It is difficult to sustain change when life offers little rest, connection or purpose. The community reinforcement approach gives this aspect particular attention and may be considered alongside coping-skills work.
A practical example
Imagine that using a substance often follows an argument and a period of isolation. The treatment discussion might identify several possible points for support: recognising that an argument is escalating, taking a safe pause, contacting someone appropriate and arranging help with the underlying relationship difficulty.
The plan should be specific enough to use. Who is available, and at what times? Is leaving the room safe? What happens when the first contact does not answer? Afterwards, the clinician and person review what worked and what failed. The purpose is not to create a perfect response on paper, but to make support more accessible in real circumstances.
This is an illustration rather than an individual treatment plan. Where a relationship involves intimidation or violence, communication practice alone is not sufficient. Safety assessment and appropriate specialist support take priority.
What does the research show?
A randomised trial of 77 people in community outpatient treatment compared standard care with standard care plus a computer-assisted CBT programme, CBT4CBT. Participants receiving the additional programme submitted more drug-negative urine samples; treatment retention was similar between groups. This supports a specific adjunctive intervention, not the claim that every recovery app or online course has the same evidence. Read the CBT4CBT trial.
A separate trial of 286 people receiving aftercare compared cognitive-behavioural relapse prevention, mindfulness-based relapse prevention and usual care. Outcomes differed by time point and measure. Standard relapse prevention delayed first drug use relative to mindfulness-based relapse prevention at six months, while later findings favoured mindfulness on some outcomes. There was no single approach that dominated every result. Read the aftercare comparison.
Ask what evidence supports the actual programme, for which substance and in which setting. A study of continuing care after initial treatment is not evidence that the same intervention is sufficient for acute withdrawal. Research should inform a plan alongside clinical judgement, preferences and access to other care.
Assessment and an individual treatment plan
The starting assessment should cover substances used, prescribed medicines, physical health, mental health and current safety. It should also explore the impact on everyday life and previous experiences of treatment. You do not need to choose a therapy or commit to a package before these needs are understood.
Goals and measures should be agreed together. Depending on clinical circumstances, review may consider substance use, risk, functioning, symptoms and engagement with care. An attendance record alone cannot show whether the treatment is helping. Ask how the clinician will respond when the agreed goals are not being met.
What a safety plan needs to include
A psychological plan and a medical safety plan are related but different. Alcohol or sedative dependence can require supervised withdrawal planning. An urge-management exercise does not make abrupt stopping safe. Our withdrawal and deprescribing guide explains why this needs appropriate professional assessment.
After reduced use or abstinence, opioid tolerance can fall. Returning to a previous dose can therefore increase overdose risk. The CDC specifically identifies loss of tolerance as an important risk factor. Ask the clinical team about overdose prevention, access to naloxone where appropriate and emergency arrangements. CDC: opioid risks and reducing them.
Suspected overdose, seizures, severe confusion or immediate danger requires urgent local help, not waiting for a scheduled therapy session. The plan should make clear who can provide routine support and which situations need emergency care.
Medication, trauma and other treatment needs
CBT may be one part of care that also includes medication for opioid-use disorder or medication for alcohol-use disorder. Necessary medication should not be withheld until psychological homework is completed. Concerns about medicines belong in a discussion with the prescriber.
Depression, trauma-related symptoms, chronic pain and other difficulties may also need treatment. Our co-occurring conditions guide explains why one diagnosis should not obscure another. A coordinated plan specifies who is responsible for each area and how relevant information is shared with consent.
Between sessions and after the course
Practice is most useful when it is achievable. A brief note, a rehearsed conversation or a small experiment may be more informative than a long diary that is impossible to maintain. Discuss adaptations for language, concentration, disability or privacy. Difficulty completing a task should prompt curiosity and adjustment, not blame.
Before treatment ends, review early warning signs, useful skills and how to re-enter care. A written plan can include realistic contacts and the circumstances in which support should increase. Recovery should not depend on remembering everything from a final appointment or managing every future difficulty alone.
Frequently asked questions
Is relapse prevention the same as general CBT?
It uses cognitive-behavioural principles but applies them to substance-related patterns and recovery risks. Ask whether the clinician offers a substance-specific programme and how medical concerns are integrated. A broad CBT qualification does not by itself explain experience with complex addiction care.
Does a return to use mean treatment has failed?
It means the situation needs review, including medical risk and the support available. Previous gains may still be meaningful. The response should identify what changed and what care is needed now, rather than interpret a setback as proof of moral failure or a reason to stop helping.
Will therapy remove every craving?
No treatment should promise that. The goal may be to recognise urges earlier and respond differently, alongside other appropriate care. Persistent or changing cravings deserve discussion. They should not be treated as evidence that you are doing the therapy incorrectly.
Can I receive CBT while taking addiction medication?
Yes, psychological treatment can be included in a plan with medication when appropriate. Coordination helps avoid conflicting advice. Do not stop prescribed treatment because therapy is described as addressing the underlying causes; medication decisions require an individual review with the prescriber.
Is online CBT equally suitable for everyone?
No. A defined digital programme has its own evidence and requirements. Privacy, clinical support, accessibility and current risk matter. Research on a supported intervention does not establish that an unguided app can replace professional assessment or provide crisis care.
How many sessions will I need?
Programmes differ in structure and duration. Ask for an initial plan, review points and arrangements afterwards. The appropriate level of care depends on the substance, severity, other health needs and practical circumstances, not simply a standard number of appointments.
Can family members help with the plan?
They may be involved when helpful, safe and agreed. Clarify what can be shared and what support they can realistically provide. Their role should not become constant surveillance. Concerned relatives may also need their own support, including approaches such as CRAFT.
Finding an appropriate next step
An initial assessment can identify medical risks, treatment priorities and the support needed to make a plan workable. The objective is appropriate care for your circumstances, not choosing a therapy label before the whole picture is understood.
Sources and further reading
- NIAAA: cognitive-behavioural coping-skills treatment resources.
- Randomised trial of computer-assisted CBT alongside outpatient care.
- Trial comparing relapse-prevention approaches in aftercare.
- CDC: opioid overdose risks and prevention.
Related conditions and concerns
These links explain the wider care context. They are not a recommendation that this approach is suitable for everyone with the condition. Use the condition treatment guide to understand alternatives and the role of clinical assessment.